HEADER OXIDOREDUCTASE 12-SEP-03 1QYV TITLE CRYSTAL STRUCTURE OF HUMAN ESTROGENIC 17BETA-HYDROXYSTEROID TITLE 2 DEHYDROGENASE COMPLEX WITH NADP COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTRADIOL 17 BETA-DEHYDROGENASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: 17-BETA-HSD 1, PLACENTAL 17-BETA-HYDROXYSTEROID COMPND 5 DEHYDROGENASE, 20 ALPHA- HYDROXYSTEROID DEHYDROGENASE, 20-ALPHA-HSD, COMPND 6 E2DH; COMPND 7 EC: 1.1.1.62 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: PLACENTA KEYWDS 17BHSD1-COFACTOR COMPLEX, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR R.SHI,S.X.LIN REVDAT 5 23-AUG-23 1QYV 1 REMARK REVDAT 4 11-OCT-17 1QYV 1 REMARK REVDAT 3 13-JUL-11 1QYV 1 VERSN REVDAT 2 24-FEB-09 1QYV 1 VERSN REVDAT 1 03-AUG-04 1QYV 0 JRNL AUTH R.SHI,S.X.LIN JRNL TITL COFACTOR HYDROGEN BONDING ONTO THE PROTEIN MAIN CHAIN IS JRNL TITL 2 CONSERVED IN THE SHORT CHAIN DEHYDROGENASE/REDUCTASE FAMILY JRNL TITL 3 AND CONTRIBUTES TO NICOTINAMIDE ORIENTATION. JRNL REF J.BIOL.CHEM. V. 279 16778 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 14966133 JRNL DOI 10.1074/JBC.M313156200 REMARK 2 REMARK 2 RESOLUTION. 1.81 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.81 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 28494 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1450 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2116 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 151 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1QYV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-SEP-03. REMARK 100 THE DEPOSITION ID IS D_1000020236. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X8C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28701 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.810 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 3.550 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.81 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.87 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.82 REMARK 200 R MERGE FOR SHELL (I) : 0.39700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: RIGID BODY REFINEMENT REMARK 200 STARTING MODEL: PDB ENTRY 1JTV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000, MAGNISUM CHLORIDE, BETA REMARK 280 -OCTYLGLUCOSIDE, HEPES, GLYCEROL, SOAKING WITH NADP, PH 7.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 300K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 61.19950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 21.95800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 61.19950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 21.95800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE SECOND PART OF THE BIOLOGICAL ASSEMBLY IS GENEARATED BY REMARK 300 THE TWO FOLD AXIS: -X, Y, -Z. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 8190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21860 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 191 REMARK 465 PHE A 192 REMARK 465 MET A 193 REMARK 465 GLU A 194 REMARK 465 LYS A 195 REMARK 465 VAL A 196 REMARK 465 LEU A 197 REMARK 465 GLY A 198 REMARK 465 GLY A 285 REMARK 465 ASP A 286 REMARK 465 VAL A 287 REMARK 465 PRO A 288 REMARK 465 ALA A 289 REMARK 465 LYS A 290 REMARK 465 ALA A 291 REMARK 465 GLU A 292 REMARK 465 ALA A 293 REMARK 465 GLY A 294 REMARK 465 ALA A 295 REMARK 465 GLU A 296 REMARK 465 ALA A 297 REMARK 465 GLY A 298 REMARK 465 GLY A 299 REMARK 465 GLY A 300 REMARK 465 ALA A 301 REMARK 465 GLY A 302 REMARK 465 PRO A 303 REMARK 465 GLY A 304 REMARK 465 ALA A 305 REMARK 465 GLU A 306 REMARK 465 ASP A 307 REMARK 465 GLU A 308 REMARK 465 ALA A 309 REMARK 465 GLY A 310 REMARK 465 ARG A 311 REMARK 465 SER A 312 REMARK 465 ALA A 313 REMARK 465 VAL A 314 REMARK 465 GLY A 315 REMARK 465 ASP A 316 REMARK 465 PRO A 317 REMARK 465 GLU A 318 REMARK 465 LEU A 319 REMARK 465 GLY A 320 REMARK 465 ASP A 321 REMARK 465 PRO A 322 REMARK 465 PRO A 323 REMARK 465 ALA A 324 REMARK 465 ALA A 325 REMARK 465 PRO A 326 REMARK 465 GLN A 327 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 257 O HOH A 725 1.90 REMARK 500 OE2 GLU A 77 O HOH A 744 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 2 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 ASP A 68 CB - CG - OD1 ANGL. DEV. = 6.6 DEGREES REMARK 500 ASP A 68 CB - CG - OD2 ANGL. DEV. = -5.9 DEGREES REMARK 500 ARG A 76 CD - NE - CZ ANGL. DEV. = 9.6 DEGREES REMARK 500 ARG A 83 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A 120 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG A 120 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 ARG A 136 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 214 NE - CZ - NH2 ANGL. DEV. = -4.9 DEGREES REMARK 500 ARG A 252 CG - CD - NE ANGL. DEV. = -16.1 DEGREES REMARK 500 ARG A 252 NH1 - CZ - NH2 ANGL. DEV. = 7.3 DEGREES REMARK 500 ARG A 252 NE - CZ - NH2 ANGL. DEV. = -5.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 115 -61.42 -103.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 361 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 600 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BSV RELATED DB: PDB REMARK 900 17B-HSD1 APOENZYME STRUCTURE REMARK 900 RELATED ID: 1FDU RELATED DB: PDB REMARK 900 17BHSD1(H221L)-ESTRADIOL-NADP COMPLEX REMARK 900 RELATED ID: 1JTV RELATED DB: PDB REMARK 900 17BHSD1-TESTOSTERONE COMPLEX REMARK 900 RELATED ID: 1QYW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ESTROGENIC 17BETA-HYDROXYSTEROID REMARK 900 DEHYDROGENASE COMLEX WITH ANDROSTANEDIONE AND NADP REMARK 900 RELATED ID: 1QYX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ESTROGENIC 17BETA-HYDROXYSTEROID REMARK 900 DEHYDROGENASE COMPLEX WITH ANDROSTENEDIONE AND NADP DBREF 1QYV A 1 327 UNP P14061 DHB1_HUMAN 1 327 SEQRES 1 A 327 ALA ARG THR VAL VAL LEU ILE THR GLY CYS SER SER GLY SEQRES 2 A 327 ILE GLY LEU HIS LEU ALA VAL ARG LEU ALA SER ASP PRO SEQRES 3 A 327 SER GLN SER PHE LYS VAL TYR ALA THR LEU ARG ASP LEU SEQRES 4 A 327 LYS THR GLN GLY ARG LEU TRP GLU ALA ALA ARG ALA LEU SEQRES 5 A 327 ALA CYS PRO PRO GLY SER LEU GLU THR LEU GLN LEU ASP SEQRES 6 A 327 VAL ARG ASP SER LYS SER VAL ALA ALA ALA ARG GLU ARG SEQRES 7 A 327 VAL THR GLU GLY ARG VAL ASP VAL LEU VAL CYS ASN ALA SEQRES 8 A 327 GLY LEU GLY LEU LEU GLY PRO LEU GLU ALA LEU GLY GLU SEQRES 9 A 327 ASP ALA VAL ALA SER VAL LEU ASP VAL ASN VAL VAL GLY SEQRES 10 A 327 THR VAL ARG MET LEU GLN ALA PHE LEU PRO ASP MET LYS SEQRES 11 A 327 ARG ARG GLY SER GLY ARG VAL LEU VAL THR GLY SER VAL SEQRES 12 A 327 GLY GLY LEU MET GLY LEU PRO PHE ASN ASP VAL TYR CYS SEQRES 13 A 327 ALA SER LYS PHE ALA LEU GLU GLY LEU CYS GLU SER LEU SEQRES 14 A 327 ALA VAL LEU LEU LEU PRO PHE GLY VAL HIS LEU SER LEU SEQRES 15 A 327 ILE GLU CYS GLY PRO VAL HIS THR ALA PHE MET GLU LYS SEQRES 16 A 327 VAL LEU GLY SER PRO GLU GLU VAL LEU ASP ARG THR ASP SEQRES 17 A 327 ILE HIS THR PHE HIS ARG PHE TYR GLN TYR LEU ALA HIS SEQRES 18 A 327 SER LYS GLN VAL PHE ARG GLU ALA ALA GLN ASN PRO GLU SEQRES 19 A 327 GLU VAL ALA GLU VAL PHE LEU THR ALA LEU ARG ALA PRO SEQRES 20 A 327 LYS PRO THR LEU ARG TYR PHE THR THR GLU ARG PHE LEU SEQRES 21 A 327 PRO LEU LEU ARG MET ARG LEU ASP ASP PRO SER GLY SER SEQRES 22 A 327 ASN TYR VAL THR ALA MET HIS ARG GLU VAL PHE GLY ASP SEQRES 23 A 327 VAL PRO ALA LYS ALA GLU ALA GLY ALA GLU ALA GLY GLY SEQRES 24 A 327 GLY ALA GLY PRO GLY ALA GLU ASP GLU ALA GLY ARG SER SEQRES 25 A 327 ALA VAL GLY ASP PRO GLU LEU GLY ASP PRO PRO ALA ALA SEQRES 26 A 327 PRO GLN HET NAP A 361 48 HET GOL A 600 6 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM GOL GLYCEROL HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 NAP C21 H28 N7 O17 P3 FORMUL 3 GOL C3 H8 O3 FORMUL 4 HOH *151(H2 O) HELIX 1 1 SER A 12 SER A 24 1 13 HELIX 2 2 ASP A 38 THR A 41 5 4 HELIX 3 3 GLN A 42 LEU A 52 1 11 HELIX 4 4 ASP A 68 ARG A 78 1 11 HELIX 5 5 PRO A 98 LEU A 102 5 5 HELIX 6 6 GLY A 103 VAL A 115 1 13 HELIX 7 7 VAL A 115 GLY A 133 1 19 HELIX 8 8 GLY A 144 LEU A 146 5 3 HELIX 9 9 ASN A 152 LEU A 174 1 23 HELIX 10 10 SER A 199 ARG A 206 1 8 HELIX 11 11 ASP A 208 ALA A 230 1 23 HELIX 12 12 ASN A 232 ALA A 246 1 15 HELIX 13 13 PHE A 259 ASP A 268 1 10 HELIX 14 14 GLY A 272 PHE A 284 1 13 SHEET 1 A 7 LEU A 59 GLN A 63 0 SHEET 2 A 7 PHE A 30 LEU A 36 1 N VAL A 32 O GLU A 60 SHEET 3 A 7 THR A 3 ILE A 7 1 N VAL A 5 O TYR A 33 SHEET 4 A 7 VAL A 86 CYS A 89 1 O VAL A 88 N LEU A 6 SHEET 5 A 7 GLY A 135 SER A 142 1 O ARG A 136 N LEU A 87 SHEET 6 A 7 VAL A 178 CYS A 185 1 O HIS A 179 N VAL A 137 SHEET 7 A 7 ARG A 252 PHE A 254 1 O TYR A 253 N GLU A 184 SITE 1 AC1 31 GLY A 9 SER A 11 SER A 12 GLY A 13 SITE 2 AC1 31 ILE A 14 ARG A 37 LEU A 64 ASP A 65 SITE 3 AC1 31 VAL A 66 ARG A 67 ASN A 90 ALA A 91 SITE 4 AC1 31 GLY A 92 VAL A 113 THR A 140 GLY A 141 SITE 5 AC1 31 SER A 142 TYR A 155 LYS A 159 CYS A 185 SITE 6 AC1 31 GLY A 186 PRO A 187 VAL A 188 THR A 190 SITE 7 AC1 31 HOH A 602 HOH A 603 HOH A 619 HOH A 626 SITE 8 AC1 31 HOH A 662 HOH A 714 HOH A 728 SITE 1 AC2 7 ARG A 252 ARG A 266 ASP A 269 PRO A 270 SITE 2 AC2 7 HOH A 615 HOH A 636 HOH A 641 CRYST1 122.399 43.916 60.450 90.00 99.36 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008170 0.000000 0.001346 0.00000 SCALE2 0.000000 0.022771 -0.000001 0.00000 SCALE3 0.000000 0.000000 0.016766 0.00000